Denial Appeal Readiness & Review Checklist
Check your appeal documentation and reference timeframes. The score describes checklist completion and does not predict appeal success. Verify your payer’s actual policy and deadline.
Denial Appeal Readiness & Review Checklist
Select a CARC denial code, target payer class, and active documentation status. Review document readiness and reference timeframes. Confirm the actual deadline and applicable policy with the payer before acting.
Denial Parameters & Clinical Evidence
Customize the denial scenario from your 835 Electronic Remittance Advice.
These are non-covered services because this is not deemed a medical necessity by the payer.
- 1Audit the denying payer's specific clinical coverage policy bulletin (CPB) against chart notes.
- 2Highlight documented conservative treatment trial failure and physical exam objective findings.
- 3Submit formal Level 1 Redetermination or Reconsideration with physician-signed LMN attached.
“Pursuant to ERISA regulations 29 CFR § 2560.503-1(h) and published Local Coverage Determination criteria, the contested services satisfy all medical necessity guidelines. Enclosed clinical records substantiate conservative management failure and objective diagnostic indicators warranting immediate overturn.”
Have Aethera Overturn This Denial For You
Our specialized Level 1/2 appeals team recovers 82%+ of denials without cost until cash is in your bank account.
Turn these Denial Overturn Predictor insights into recovered cash
Tired of fighting payer denial sweeps one claim at a time? Aethera's specialized denial resolution team manages 100% of Level 1, 2, and external review appeals electronically with an 82%+ recovery rate. Let our senior AAPC-certified billing team audit 50 of your active claims or past denials — completely free, with guaranteed under-48-hour findings.
Test our scrub rules and appeal workflow on 50 real claims. Zero commitment, no credit card required.
Upload your aging report for instant benchmark comparisons against MGMA standards and recoverable cash projections.